MBC phase 3
Hopefully Panc should be settled soon and favorably.... It will be interesting to see if we try it alone or partner.
Just curious if anyone has concern with the new guidance for the mbc phase 3 trial which is now 550 patients as compared to the original 400 patients with a spa in the original December 5th 2017 press release from onc.
One would think that with all they learned from the aware1 , bracelet and new biomarkers that I thought it was supposed to reduce trial time, derisk the trial and lower the patient numbers especially with the use of the biomarkers...
Just curious on thoughts as I do find it confusing that we will now basically be running the same trial but with a much larger number of patients.
Thanks for the thoughts